Trial intelligence / Profile preview

Nebulized Magnesium Sulfate in Pediatric Asthma Exacerbation

NCT01584726Phase 3Unknown

Sponsor
Hamad Medical Corporation
Start
Dec 2012
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium sulfate in asthma, sponsored by Hamad Medical Corporation. Status: unknown.

02

Drugs

magnesium sulfate
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01584726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01584726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call